Furthermore, fibroblasts from the clinically affected skin of patients with SSc secrete and deposit into their extracellular matrix significantly more IGFBP-5 compared to fibroblasts from the patients’ clinically unaffected skin [11]. The gene discussed is IGFBP5; the disease is systemic sclerosis.